Want to join the conversation?
Chicago, Illinois-based $CME said in its non-transaction related business it had double-digit growth within both market data and its portion of the S&P Dow Index business. These two line items make up approx. 25% of pre-tax income. $CME has consistently expanded its global participation and had a record level of non-US volume and revenue in 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?